Applying for a new CPT code is a daunting and highly confidential process. A successful application at the AMA CPT Editorial Panel meeting depends on hitting some specific benchmarks, explains Kevin Corcoran, who assisted ELT Sight in its successful reimbursement journey, resulting in two new Category III CPT codes for its excimer laser trabeculostomy procedure.
On April 29, microinvasive glaucoma surgery (MIGS) company ELT Sight Inc. announced that the American Medical Association (AMA) had approved two new Category III CPT codes for the company’s ExTra Excimer Laser Trabeculostomy (ELT) procedure. The two codes, to be used for reporting trabeculostomy ab interno by laser with or without the use of an ophthalmic endoscope, become effective January 1, 2021 (see the CPT Editorial Summary of Panel Actions, Tab #35). The backstory leading up to the company’s Code Change Application presentation at the February 6-8 AMA CPT Editorial Panel meeting in San Francisco involves the culmination of more than eight years of effort by the ELT Sight team and its reimbursement consulting firm, Corcoran Consulting Group.